- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| ONWARD MEDICAL NV ADR Aktie jetzt für 0€ handeln | |||||
| 26.05. | ONWARD Medical NV: ONWARD Medical Reports First Quarter 2026 Results with Strong Commercial Momentum and Key Clinical Milestones | 1.180 | GlobeNewswire (Europe) | EINDHOVEN, the Netherlands, May 26, 2026 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD - US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function... ► Artikel lesen | |
| 19.05. | ONWARD Medical NV: ONWARD Medical to Announce First Quarter 2026 Results on May 26, 2026 | 598 | GlobeNewswire (Europe) | EINDHOVEN, The Netherlands, May 19, 2026 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD - US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function... ► Artikel lesen | |
| 13.05. | ONWARD Medical NV: ONWARD Medical Announces Results of the 2026 Annual General Meeting of Shareholders | 873 | GlobeNewswire (Europe) | THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014)
Shareholders approve all proposed resolutions
EINDHOVEN,... ► Artikel lesen | |
| 20.04. | ONWARD Medical NV: ONWARD Medical Publishes Closing of Bookbuild Offering | 1.072 | GlobeNewswire (Europe) | THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE (7)(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014)
EINDHOVEN, the Netherlands, April 20, 2026 (GLOBE NEWSWIRE)... ► Artikel lesen | |
| 17.04. | ONWARD Medical schliesst Kapitalerhöhung über 40 Mio. Euro erfolgreich ab | 897 | Moneycab | Eindoven / Lausanne - ONWARD Medical N.V. (Euronext: ONWD - US-ADR: ONWRY), das Neurotechnologie-Unternehmen, das wegweisende Therapien zur Wiederherstellung von Bewegung, Funktion und Unabhängigkeit... ► Artikel lesen | |
| 17.04. | ONWARD Medical schliesst Kapitalerhöhung über 40 Millionen Euro erfolgreich ab | 733 | Moneycab | Eindoven / Lausanne - ONWARD Medical N.V. (Euronext: ONWD - US-ADR: ONWRY), das Neurotechnologie-Unternehmen, das wegweisende Therapien zur Wiederherstellung von Bewegung, Funktion und Unabhängigkeit... ► Artikel lesen | |
| 16.04. | ONWARD Medical NV: ONWARD Medical Successfully Raises over EUR 40 Million in Capital Increase | 644 | GlobeNewswire (Europe) | NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER... ► Artikel lesen | |
| 15.04. | ONWARD Medical NV: ONWARD Medical Launches Capital Increase for Indicative Amount of EUR 40 Million | 689 | GlobeNewswire (Europe) | NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER... ► Artikel lesen | |
| 02.04. | Onward Medical N.V. reports FY results | 22 | Seeking Alpha | ||
| 01.04. | ONWARD Medical NV: ONWARD Medical Publishes Convocation of the 2026 Annual General Meeting of Shareholders and Proposed Resolutions | 625 | GlobeNewswire (Europe) | EINDHOVEN, the Netherlands, April 01, 2026 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD - US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function... ► Artikel lesen | |
| 31.03. | ONWARD Medical NV: ONWARD Medical Reports Full Year 2025 Financial and Operating Results, Highlighting Strong US Commercial Performance and Major Pipeline Milestones | 1.125 | GlobeNewswire (Europe) | THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014)
EINDHOVEN, the Netherlands, March 31, 2026 (GLOBE NEWSWIRE) --... ► Artikel lesen | |
| 23.03. | ONWARD Medical NV: ONWARD Medical Schedules Webcast to Report Full-Year 2025 Financial Results and Provide Business Update | 620 | GlobeNewswire (Europe) | EINDHOVEN, the Netherlands, March 23, 2026 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD - US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function... ► Artikel lesen | |
| 04.02. | ONWARD Medical NV: ONWARD Medical Announces First Participant Enrolled in Global Pivotal Study Evaluating ARC-IM System to Address Blood Pressure Instability After Spinal Cord Injury | 1.031 | GlobeNewswire (Europe) | Empower BP is a landmark global pivotal study evaluating the safety and effectiveness
of the implantable ARC-IM System
to address blood pressure instability after spinal cord injury (SCI)Blood... ► Artikel lesen | |
| 29.01. | XFRA NEW INSTRUMENTS AVAILABLE ON 29.01.2026 | 1.099 | Xetra Newsboard | The following instruments on XETRA do have their first trading 29.01.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 29.01.2026
Aktien
1 CA02074J5017 Alpha Cognition Inc.
2... ► Artikel lesen | |
| 23.01. | ONWARD Medical NV: ONWARD Medical Appoints Ali Kiboro as Chief Financial Officer | 908 | GlobeNewswire (Europe) | EINDHOVEN, the Netherlands, Jan. 23, 2026 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD - US ADR: ONWRY), the neurotechnology company pioneering spinal cord stimulation therapies to restore... ► Artikel lesen | |
| 22.01. | ONWARD Medical NV: ONWARD Medical Completes Two Additional Brain-Computer Interface Implants Paired with Spinal Cord Stimulation Technology to Restore Thought-Driven Movement | 999 | GlobeNewswire (Europe) | Investigational ARC-BCI Therapy is being developed to restore thought-driven movement in people living with spinal cord injuries and other movement disabilitiesARC-BCI is the world's first and most... ► Artikel lesen | |
| 24.11.25 | ONWARD Medical NV: ONWARD Medical Drives Strong US ARC-EX Adoption and Achieves Important Scientific and Regulatory Milestones in Q3 2025 | 1.092 | GlobeNewswire (Europe) | EINDHOVEN, the Netherlands, Nov. 24, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD - US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function... ► Artikel lesen | |
| 17.11.25 | ONWARD Medical NV: ONWARD Medical Receives FDA 510(k) Clearance Expanding ARC-EX System Indication for Home Use | 3.134 | GlobeNewswire (Europe) | THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014)
US FDA clearance now allows use of the ARC-EX® System both in... ► Artikel lesen | |
| 28.10.25 | ONWARD Medical NV: ONWARD Medical Publishes Closing of Bookbuild Offering | 730 | GlobeNewswire (Europe) | NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER... ► Artikel lesen | |
| 24.10.25 | EQS-News: Ottobock SE & Co. KGaA: Ottobock investiert erneut in NeuroTech-Unternehmen ONWARD Medical | 1.140 | EQS Group (DE) | EQS-News: Ottobock SE & Co. KGaA
/ Schlagwort(e): Beteiligung/Unternehmensbeteiligung
Ottobock investiert erneut in NeuroTech-Unternehmen ONWARD® Medical... ► Artikel lesen |
1 2 Weiter >>
27 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 46,345 | +1,09 % | EQS-News: Fresenius SE & Co. KGaA: Fresenius verkauft 7,8 Millionen Fresenius Medical Care-Aktien im Wert von rund 300 Millionen Euro | EQS-News: Fresenius SE & Co. KGaA
/ Schlagwort(e): Beteiligung/Unternehmensbeteiligung
Fresenius verkauft 7,8 Millionen Fresenius Medical Care-Aktien im Wert von rund 300 Millionen... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 39,260 | -1,11 % | Siemens-Healthineers-Chef: 'Mir gefällt dieses Rumgenörgel nicht' | BERLIN (dpa-AFX) - Der Vorstandvorsitzende des Dax -Konzerns Siemens Healthineers, Bernhard Montag, hat die Anspruchshaltung vieler Wirtschaftslenker in Deutschland gegenüber der Politik kritisiert.... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 61,36 | +0,02 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,360 | 0,00 % | Fresenius macht bei FMC Kasse - was jetzt zählt | ||
| ALIGNMENT HEALTHCARE | 13,920 | +0,14 % | Alignment Healthcare Reports Second Quarter 2026 Results, Surpassing High End of Guidance Across All Key Metrics | Generates $1.3 billion in total revenue, representing 31.6% growth year-over-year Grows Medicare Advantage membership 31.5% year-over-year to approximately 294,100 membersRaises the midpoint of all... ► Artikel lesen | |
| HEARTFLOW | 48,920 | -0,04 % | Biotech Stocks At 52-Week Highs - Vogenx, Pharvaris, Solventum, Inhibikase Therapeutics, HeartFlow | WASHINGTON (dpa-AFX) - The following biotech stocks reached a 52-week high on August 24, 2026, driven by positive results from clinical trials or an upcoming conference participation. Vogenx... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 12,150 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 31,280 | -2,00 % | 2,2 Milliarden Menschen mit Sehbeeinträchtigungen: Warum Augengesundheit für Carl Zeiss Meditec, Alcon & Co. zum Technologiemarkt wird - und wo Rise Nano Optics ins Spiel kommt | ||
| AVEANNA HEALTHCARE | 13,605 | -0,11 % | Aveanna Healthcare (AVAH) Just Ended A Four-Year Rate Fight | ||
| PROGYNY | 26,375 | 0,00 % | Progyny vor dem Boom?: Wells Fargo sieht bei dieser "Kinderwunsch-Aktie" 42 % Kurspotenzial | © Foto: SOPA Images - Sipa USAWells Fargo traut Progyny 42 Prozent Kurspotenzial zu. Das Geschäft mit Kinderwunsch-Leistungen könnte jetzt zum großen Wachstumstreiber werden Enthaltene Werte: US74340E1038Den... ► Artikel lesen | |
| BILLIONTOONE | 96,27 | 0,00 % | BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar | Renowned physician-scientist, former Director of Frederick National Laboratory, and one of the nation's most accomplished leaders in oncology joins BillionToOne... ► Artikel lesen | |
| GENEDX | 90,30 | +0,02 % | GeneDx study shows rapid genome sequencing benefits beyond ICUs | ||
| GERRESHEIMER | 25,400 | -0,70 % | EQS-Adhoc: Gerresheimer AG: Uwe Röhrhoff beendet Mandat als Interim-CEO | EQS-Ad-hoc: Gerresheimer AG / Schlagwort(e): Personalentscheidungen / Vorstand/Bedeutende Verträge
Gerresheimer AG: Uwe Röhrhoff beendet Mandat als Interim-CEO
24.08.2026 / 19:29... ► Artikel lesen | |
| DRAEGERWERK | 112,20 | +0,90 % | dpa-AFX-Überblick: UNTERNEHMEN vom 10.08.2026 - 15.15 Uhr | ROUNDUP: Hypoport bestätigt Jahresziele für 2026 - Aktie legt zu BERLIN - Der Finanzdienstleister Hypoport sieht sich auf Kurs zu seinen Jahreszielen. "Die geopolitischen Spannungen des ersten Halbjahres... ► Artikel lesen | |
| CLEARPOINT NEURO | 16,370 | 0,00 % | ClearPoint Neuro, Inc.: ClearPoint Neuro Reports Second Quarter 2026 Results | Positive BioPharma Partner Regulatory Progress and Early Success in Focused Ultrasound Technology Platform Expansion SOLANA BEACH, CA / ACCESS Newswire / August 3, 2026 / ClearPoint Neuro, Inc. (Nasdaq:CLPT)... ► Artikel lesen |
Das Unternehmen ONWARD MEDICAL NV ADR kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von +0,020 (+0,95 %) liegt der Kurs bei 2,120 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ONWARD MEDICAL NV ADR finden Sie auf Wallstreet Online.